Efficacy, safety and immunogenicity of subcutaneous infliximab (ct-p13 sc) monotherapy versus combination therapy with immunosuppressants - post hoc analysis of liberty-cd and liberty-uc study

INFLAMMATORY BOWEL DISEASES(2024)

引用 0|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要